FDA Guidance Documents·· 原文未提供具体时分
Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use: Guidance for Industry and Food and Drug Administration Staff
Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use: Guidance for Industry and Food and Drug Administration Staff
AI 导读
FDA 官方历史目录记录；Final guidance；发布日期：2020-07-20。官方主题：Cellular & Gene Therapy, Tissue。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov